Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

NCT03760263 is registered in ClinicalTrials.gov with Sentara Norfolk General Hospital as lead sponsor.

NCT NCT03760263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03760263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Lead sponsor
Sentara Norfolk General Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 16, 2020
Completion date
November 1, 2023
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transplant;failure,kidney